secwatch.observer — SEC 8-K summary
======================================

Issuer:     Comera Life Sciences Holdings, Inc. (—)
CIK:        0001907685
Form:       8-K
Filed at:   2023-12-29T23:59:59+00:00
Accession:  0000950170-23-073905
Event type: debt
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Comera Life Sciences raises $1.5M via 12% senior secured convertible notes due 2024 with warrants
--------------------------------------------------------------------------------

- $1.5M aggregate principal of 12.0% Senior Secured Convertible Notes due Dec 29, 2024; convertible at $0.055/share, interest payable monthly.
- Warrants issued for 200% of Note Shares, exercisable immediately at $0.055/share for 5 years.
- Purchasers include existing major stockholders Charles Cherington and trusts controlled by David Soane (each >20% prior).
- Purchasers granted Share Purchase right to buy all outstanding stock at $0.0825 or 1.5x closing price; exclusivity through Dec 2024.
- Notes secured by first priority lien on substantially all assets; subject to affirmative/negative covenants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1907685/000095017023073905/0000950170-23-073905-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1907685/000095017023073905/cmra-20231229.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-073905

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer